---
document_datetime: 2023-09-21 19:55:34
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/givlaari-epar-all-authorised-presentations_en.pdf
document_name: givlaari-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6638772
conversion_datetime: 2025-12-18 11:12:12.714709
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EMA number       | (Invented) name   | Strength   | Pharmaceutical form    | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/20/1428/001 | Givlaari          | 189 mg/mL  | Solution for injection | Subcutaneous use          | Vial (glass)          | 1 mL                      | 1 vial      |